{"status":"ok","message-type":"work","message-version":"1.0.0","message":{"indexed":{"date-parts":[[2026,8,17]],"date-time":"2026-08-17T16:50:27Z","timestamp":1786985427245,"version":"build-2736575974"},"reference-count":35,"publisher":"Elsevier BV","license":[{"start":{"date-parts":[[2025,2,1]],"date-time":"2025-02-01T00:00:00Z","timestamp":1738368000000},"content-version":"tdm","delay-in-days":0,"URL":"https:\/\/www.elsevier.com\/tdm\/userlicense\/1.0\/"},{"start":{"date-parts":[[2025,2,1]],"date-time":"2025-02-01T00:00:00Z","timestamp":1738368000000},"content-version":"tdm","delay-in-days":0,"URL":"https:\/\/www.elsevier.com\/legal\/tdmrep-license"},{"start":{"date-parts":[[2025,2,1]],"date-time":"2025-02-01T00:00:00Z","timestamp":1738368000000},"content-version":"stm-asf","delay-in-days":0,"URL":"https:\/\/doi.org\/10.15223\/policy-017"},{"start":{"date-parts":[[2025,2,1]],"date-time":"2025-02-01T00:00:00Z","timestamp":1738368000000},"content-version":"stm-asf","delay-in-days":0,"URL":"https:\/\/doi.org\/10.15223\/policy-037"},{"start":{"date-parts":[[2025,2,1]],"date-time":"2025-02-01T00:00:00Z","timestamp":1738368000000},"content-version":"stm-asf","delay-in-days":0,"URL":"https:\/\/doi.org\/10.15223\/policy-012"},{"start":{"date-parts":[[2025,2,1]],"date-time":"2025-02-01T00:00:00Z","timestamp":1738368000000},"content-version":"stm-asf","delay-in-days":0,"URL":"https:\/\/doi.org\/10.15223\/policy-029"},{"start":{"date-parts":[[2025,2,1]],"date-time":"2025-02-01T00:00:00Z","timestamp":1738368000000},"content-version":"stm-asf","delay-in-days":0,"URL":"https:\/\/doi.org\/10.15223\/policy-004"}],"content-domain":{"domain":["elsevier.com","sciencedirect.com"],"crossmark-restriction":true},"short-container-title":["Bioorganic & Medicinal Chemistry"],"published-print":{"date-parts":[[2025,2]]},"DOI":"10.1016\/j.bmc.2024.118052","type":"journal-article","created":{"date-parts":[[2024,12,24]],"date-time":"2024-12-24T20:28:45Z","timestamp":1735072125000},"page":"118052","update-policy":"https:\/\/doi.org\/10.1016\/elsevier_cm_policy","source":"Crossref","is-referenced-by-count":5,"special_numbering":"C","title":["Synthetic glycol-split heparin tri- and tetrasaccharides provide new insights into structural peculiarities for antiheparanase activity"],"prefix":"10.1016","volume":"118","author":[{"ORCID":"https:\/\/orcid.org\/0000-0001-6118-3750","authenticated-orcid":false,"given":"Minghong","family":"Ni","sequence":"first","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Michela","family":"Parafioriti","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Emiliano","family":"Esposito","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Margherita","family":"Danzi","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Ornela","family":"Cano","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Laura","family":"Muzi","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Yasmin","family":"Kayal","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Vito","family":"Ferro","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Israel","family":"Vlodavsky","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Stefano","family":"Elli","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Annamaria","family":"Naggi","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Maurice","family":"Petitou","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Marco","family":"Guerrini","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]}],"member":"78","reference":[{"issue":"7","key":"10.1016\/j.bmc.2024.118052_b0005","article-title":"Proteoglycans","volume":"3","author":"Sarrazin","year":"2011","journal-title":"Cold Spring Harbor Perspect O Biologico"},{"key":"10.1016\/j.bmc.2024.118052_b0010","doi-asserted-by":"crossref","first-page":"4215","DOI":"10.3390\/molecules25184215","article-title":"Heparan sulfate proteoglycans biosynthesis and post synthesis mechanisms combine few enzymes and few core proteins to generate extensive structural and functional diversity","volume":"25","author":"Annaval","year":"2020","journal-title":"Molecules"},{"key":"10.1016\/j.bmc.2024.118052_b0015","doi-asserted-by":"crossref","first-page":"e6","DOI":"10.1002\/pgr2.6","article-title":"Heparanase-A single protein with multiple enzymatic and nonenzymatic functions","volume":"1","author":"Vlodavsky","year":"2023","journal-title":"Proteogly Res"},{"key":"10.1016\/j.bmc.2024.118052_b0020","doi-asserted-by":"crossref","first-page":"129","DOI":"10.1146\/annurev-biochem-060713-035314","article-title":"Demystifying heparan sulfate-protein interactions","volume":"83","author":"Xu","year":"2014","journal-title":"Ann Rev Biochem"},{"key":"10.1016\/j.bmc.2024.118052_b0025","doi-asserted-by":"crossref","first-page":"2057","DOI":"10.2174\/138161207781039742","article-title":"Heparanase: structure, biological function, and inhibition by heparin-derived mimetics of heparan sulfate","volume":"13","author":"Vlodavsky","year":"2007","journal-title":"Curr Pharmaceut Des"},{"key":"10.1016\/j.bmc.2024.118052_b0030","doi-asserted-by":"crossref","first-page":"30377","DOI":"10.1074\/jbc.M111.254789","article-title":"Heparanase-mediated loss of nuclear syndecan-1 enhances histone acetyltransferase (HAT) activity to promote expression of genes that drive an aggressive tumor phenotype","volume":"286","author":"Purushothaman","year":"2011","journal-title":"J Biol Chem"},{"key":"10.1016\/j.bmc.2024.118052_b0035","doi-asserted-by":"crossref","first-page":"1102","DOI":"10.1093\/jnci\/djy032","article-title":"Involvement of heparanase in the pathogenesis of mesothelioma: basic aspects and clinical applications","volume":"110","author":"Barash","year":"2018","journal-title":"J Natl Cancer Inst"},{"key":"10.1016\/j.bmc.2024.118052_b0040","doi-asserted-by":"crossref","first-page":"220","DOI":"10.1016\/j.matbio.2013.03.001","article-title":"Heparanase: Multiple functions in inflammation, diabetes and atherosclerosis","volume":"32","author":"Vlodavsky","year":"2013","journal-title":"Matrix Biol"},{"key":"10.1016\/j.bmc.2024.118052_b0045","doi-asserted-by":"crossref","DOI":"10.3389\/fimmu.2020.575047","article-title":"Increased plasma heparanase activity in COVID-19 patients","volume":"11","author":"Buijsers","year":"2020","journal-title":"Front Immunol"},{"key":"10.1016\/j.bmc.2024.118052_b0050","doi-asserted-by":"crossref","DOI":"10.4028\/b-wjQRP6","article-title":"A novel drug candidate for sepsis targeting heparanase by inhibiting cytokine storm","volume":"11","author":"Wang","year":"2024","journal-title":"Adv Sci"},{"key":"10.1016\/j.bmc.2024.118052_b0055","doi-asserted-by":"crossref","first-page":"15","DOI":"10.1016\/j.antiviral.2004.01.001","article-title":"The low molecular weight heparan sulfate-mimetic, PI-88, inhibits cell-to-cell spread of herpes simplex virus","volume":"63","author":"Nyberg","year":"2004","journal-title":"Antiv Res"},{"key":"10.1016\/j.bmc.2024.118052_b0060","doi-asserted-by":"crossref","DOI":"10.1002\/anie.202309838","article-title":"Synthetic heparanase inhibitors can prevent herpes simplex viral spread","volume":"62","author":"Chopra","year":"2023","journal-title":"Angew Chem Ind Ed"},{"key":"10.1016\/j.bmc.2024.118052_b0065","doi-asserted-by":"crossref","first-page":"360","DOI":"10.1016\/j.isci.2019.04.034","article-title":"Targeting heparanase in cancer: inhibition by synthetic, chemically modified and natural compounds","volume":"15","author":"Mohan","year":"2019","journal-title":"Iscience"},{"key":"10.1016\/j.bmc.2024.118052_b0070","doi-asserted-by":"crossref","first-page":"1","DOI":"10.1038\/sj.bjp.0707182","article-title":"Heparanase: a target for drug discovery in cancer and inflammation","volume":"151","author":"McKenzie","year":"2007","journal-title":"Brit J Pharmacol"},{"key":"10.1016\/j.bmc.2024.118052_b0075","doi-asserted-by":"crossref","first-page":"1316","DOI":"10.3389\/fonc.2019.01316","article-title":"Heparanase: a chanllenging cancer drug target","volume":"9","author":"Coombe","year":"2019","journal-title":"Front Oncol"},{"key":"10.1016\/j.bmc.2024.118052_b0080","doi-asserted-by":"crossref","first-page":"1","DOI":"10.1073\/pnas.2203167119","article-title":"Mechanism-based heparanase inhibitors reduce cancer metastasis in vivo","volume":"119","author":"de Boer","year":"2022","journal-title":"PNAS."},{"key":"10.1016\/j.bmc.2024.118052_b0085","doi-asserted-by":"crossref","first-page":"1382","DOI":"10.1158\/1078-0432.CCR-10-2476","article-title":"SST0001, a chemically modified heparin, inhibits myeloma growth and angiogenesis via disruption of the heparanase\/syndecan-1 axis","volume":"17","author":"Ritchie","year":"2011","journal-title":"Clin Cancer Res off J Am Assoc Cancer Res"},{"key":"10.1016\/j.bmc.2024.118052_b0090","doi-asserted-by":"crossref","first-page":"640","DOI":"10.1093\/glycob\/cww003","article-title":"Kinetic analysis and molecular modeling of the inhibition mechanism of roneparstat (SST0001) on human heparinase","volume":"26","author":"Pala","year":"2016","journal-title":"Glycobiology"},{"key":"10.1016\/j.bmc.2024.118052_b0095","doi-asserted-by":"crossref","unstructured":"Elli S, Guerrini M. Molecular aspects of heparanase interaction with heparan sulfate, heparin and glycol split heparin. In: Vlodavsky I, Sanderson R, Ilan N, editors. Advances in experimental medicine and biology, heparanase from basic research to clinical applications. Springer. 2020;1221. doi: 10.1007\/978-3-030-34521-1_6.","DOI":"10.1007\/978-3-030-34521-1_6"},{"key":"10.1016\/j.bmc.2024.118052_b0100","doi-asserted-by":"crossref","first-page":"1602","DOI":"10.3390\/molecules21111602","article-title":"Investigating glycol-split-heparin-derived inhibitors of heparanase: a study of synthetic trisaccharides","volume":"21","author":"Ni","year":"2016","journal-title":"Molecules"},{"key":"10.1016\/j.bmc.2024.118052_b0105","doi-asserted-by":"crossref","first-page":"211","DOI":"10.3390\/cells13030211","article-title":"A new synthesized dicarboxylated oxy-heparin efficiently attenuates tumor growth and metastasis","volume":"13","author":"Li","year":"2024","journal-title":"Cells"},{"key":"10.1016\/j.bmc.2024.118052_b0110","doi-asserted-by":"crossref","first-page":"67","DOI":"10.1016\/0008-6215(87)80268-9","article-title":"Synthesis of heparin fragments: a methyl \u03b1-pentaoside with high affinity for antithrombin III","volume":"167","author":"Petitou","year":"1987","journal-title":"Carbohydr Res"},{"key":"10.1016\/j.bmc.2024.118052_b0115","doi-asserted-by":"crossref","first-page":"5725","DOI":"10.1016\/S0040-4039(99)01084-9","article-title":"Synthesis and biological activity of oligomer-model compounds containing units of a key platelet-binding disaccharide of heparin","volume":"40","author":"Koshida","year":"1999","journal-title":"Tetrahedr Lett"},{"key":"10.1016\/j.bmc.2024.118052_b0120","doi-asserted-by":"crossref","first-page":"11457","DOI":"10.1021\/acs.chemrev.8b00442","article-title":"Site-selective functionalization of hydroxyl groups in carbohydrate derivatives","volume":"118","author":"Dimakos","year":"2018","journal-title":"Chem Rev"},{"key":"10.1016\/j.bmc.2024.118052_b0125","doi-asserted-by":"crossref","first-page":"9086","DOI":"10.1021\/jo961257b","article-title":"A reagent for selective deprotection of alkyl acetates","volume":"61","author":"Xu","year":"1996","journal-title":"J Org Chem"},{"key":"10.1016\/j.bmc.2024.118052_b0130","doi-asserted-by":"crossref","first-page":"10106","DOI":"10.1002\/chem.201101108","article-title":"Divergent heparin oligosaccharide synthesis with preinstalled sulfate esters","volume":"17","author":"Tiruchinapally","year":"2011","journal-title":"Chemistry"},{"key":"10.1016\/j.bmc.2024.118052_b0135","doi-asserted-by":"crossref","first-page":"434","DOI":"10.1002\/anie.199304341","article-title":"A short synthetic route towards a biologically active heparin-like pentasaccharide with a pseudo-alternating sequence","volume":"32","author":"Lucas","year":"1993","journal-title":"Angew Chem (Int Ed Engl)"},{"key":"10.1016\/j.bmc.2024.118052_b0140","doi-asserted-by":"crossref","first-page":"157","DOI":"10.1016\/0008-6215(90)84164-P","article-title":"Conformer populations of L-iduronic acid residues in glycosamineoglycan sequences","volume":"195","author":"Ferro","year":"1990","journal-title":"Carbohydr Res"},{"key":"10.1016\/j.bmc.2024.118052_b0145","doi-asserted-by":"crossref","first-page":"103","DOI":"10.1042\/bj1730103","article-title":"Periodate oxidation and the shapes of glycosaminoglycuronans in solution","volume":"173","author":"Scott","year":"1978","journal-title":"Biochem J"},{"key":"10.1016\/j.bmc.2024.118052_b0150","doi-asserted-by":"crossref","DOI":"10.1016\/j.carres.2020.108172","article-title":"Efficient Selective Deacetylation of complex oligosaccharides using the neutral organotin catalyst [t-Bu2Sn(OH)Cl]2","volume":"498","author":"Ni","year":"2020","journal-title":"Carbohydr Res"},{"key":"10.1016\/j.bmc.2024.118052_b0155","doi-asserted-by":"crossref","DOI":"10.1007\/978-3-030-34521-1_20","article-title":"Non-anticoagulant heparins as heparanase inhibitors","volume":"493\u2013522","author":"Cassinelli","year":"2020","journal-title":"Adv Exp Med Biol Heparan: Basic Res Clin Appl"},{"key":"10.1016\/j.bmc.2024.118052_b0160","doi-asserted-by":"crossref","DOI":"10.1371\/journal.pone.0021106","article-title":"M402, a novel heparan sulfate mimetic, targets multiple pathways implicated in tumor progression and metastasis","volume":"6","author":"Zhou","year":"2011","journal-title":"PLoS One"},{"key":"10.1016\/j.bmc.2024.118052_b0165","doi-asserted-by":"crossref","first-page":"227","DOI":"10.1007\/978-1-0716-2946-8_16","article-title":"An enzymatic activity assay for heparanase that is useful for evaluating clinically relevant inhibitors and studying kinetics","volume":"2619","author":"Hammond","year":"2023","journal-title":"Methods Mol Biol"},{"key":"10.1016\/j.bmc.2024.118052_b0170","doi-asserted-by":"crossref","DOI":"10.1002\/chem.202104222","article-title":"Structural insights into pixatimod (PG545) inhibition of heparanase, a key enzyme in cancer and viral infections","volume":"28","author":"Chhabra","year":"2022","journal-title":"Chem A Euro J"},{"key":"10.1016\/j.bmc.2024.118052_b0175","doi-asserted-by":"crossref","first-page":"185","DOI":"10.1016\/j.bbrc.2013.11.079","article-title":"1H NMR spectroscopic studies establish that heparanase is a retaining glycosidase","volume":"443","author":"Wilson","year":"2014","journal-title":"Biochem Biophys Res Commun"}],"container-title":["Bioorganic & Medicinal Chemistry"],"original-title":[],"language":"en","link":[{"URL":"https:\/\/api.elsevier.com\/content\/article\/PII:S0968089624004668?httpAccept=text\/xml","content-type":"text\/xml","content-version":"vor","intended-application":"text-mining"},{"URL":"https:\/\/api.elsevier.com\/content\/article\/PII:S0968089624004668?httpAccept=text\/plain","content-type":"text\/plain","content-version":"vor","intended-application":"text-mining"}],"deposited":{"date-parts":[[2025,11,5]],"date-time":"2025-11-05T12:57:01Z","timestamp":1762347421000},"score":1,"resource":{"primary":{"URL":"https:\/\/linkinghub.elsevier.com\/retrieve\/pii\/S0968089624004668"}},"subtitle":[],"short-title":[],"issued":{"date-parts":[[2025,2]]},"references-count":35,"alternative-id":["S0968089624004668"],"URL":"https:\/\/doi.org\/10.1016\/j.bmc.2024.118052","relation":{},"ISSN":["0968-0896"],"issn-type":[{"value":"0968-0896","type":"print"}],"subject":[],"published":{"date-parts":[[2025,2]]},"assertion":[{"value":"Elsevier","name":"publisher","label":"This article is maintained by"},{"value":"Synthetic glycol-split heparin tri- and tetrasaccharides provide new insights into structural peculiarities for antiheparanase activity","name":"articletitle","label":"Article Title"},{"value":"Bioorganic & Medicinal Chemistry","name":"journaltitle","label":"Journal Title"},{"value":"https:\/\/doi.org\/10.1016\/j.bmc.2024.118052","name":"articlelink","label":"CrossRef DOI link to publisher maintained version"},{"value":"article","name":"content_type","label":"Content Type"},{"value":"\u00a9 2024 Elsevier Ltd. All rights are reserved, including those for text and data mining, AI training, and similar technologies.","name":"copyright","label":"Copyright"}],"article-number":"118052"}}